{"entity":{"id":"meredith-irwin","kind":"person","name":"Meredith Irwin","aka":[],"tldr":"Paediatric oncologist and neuroblastoma researcher who serves as Paediatrician-in-Chief at SickKids in Toronto.","summary":"Meredith Irwin, MD, is Paediatrician-in-Chief at The Hospital for Sick Children (SickKids) and Chair of Paediatrics at the University of Toronto. A paediatric oncologist, her research has focused on neuroblastoma biology, including p53-family signalling and risk stratification, and she has contributed to Children's Oncology Group neuroblastoma classification and biology committees.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.sickkids.ca/en/about/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Irwin+MS%5BAuthor%5D+neuroblastoma"}],"tags":["leadership","clinician-scientist","paediatric oncology","neuroblastoma"],"related":[],"cancers":["neuroblastoma"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["sickkids"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"role":"Paediatrician-in-Chief","institutionId":"sickkids","specialisms":["Paediatric oncology","Neuroblastoma","Tumour biology"],"profiles":[{"label":"Institution profile","url":"https://www.sickkids.ca/en/about/leadership/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Irwin+MS%5BAuthor%5D+neuroblastoma"}],"papers":[{"title":"An upfront immunomodulatory therapy protocol for pediatric opsoclonus‐myoclonus syndrome","journal":"Pediatric Blood & Cancer","year":2019,"doi":"10.1002/pbc.27776"}],"orcid":"0000-0002-2452-5181"},"route":"/people/meredith-irwin/","neighbours":{"cancer":[{"id":"neuroblastoma","kind":"cancer","name":"Neuroblastoma (paediatric)","route":"/cancers/neuroblastoma/"}],"institution":[{"id":"sickkids","kind":"institution","name":"The Hospital for Sick Children (SickKids)","route":"/institutions/sickkids/"}]}}